MediCarbone
Developer of a minimally invasive intramedullary fixation system that combines a carbon-fiber-reinforced composite sleeve, an injectable photocurable polymeric resin, and an AI-based design tool to produce patient-specific intramedullary implants. Activities described include prototype development, patenting, preclinical planning, and preparation for regulatory submissions using FDA-cleared polymer components.
Industries
Nr. of Employees
small (1-50)
MediCarbone
2820 E Fort Lowell Rd Tucson, Arizona 85716, USA
Patents
Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization
US-11925394-B1
View DetailsMethod of creating biocompatible polymeric resin systems for bone repair and management
US-11925401-B1
View Details
Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization
US-11925394-B1
View DetailsMethod of creating biocompatible polymeric resin systems for bone repair and management
US-11925401-B1
View DetailsProducts
Intramedullary fixation system (composite sleeve + photocurable resin + AI customization)
A system composed of a two-layer carbon-fiber-reinforced sleeve inserted in the intramedullary cavity, an injectable photocurable resin cured in situ via light, and an AI tool for patient-specific sizing and material tuning.
Intramedullary fixation system (composite sleeve + photocurable resin + AI customization)
A system composed of a two-layer carbon-fiber-reinforced sleeve inserted in the intramedullary cavity, an injectable photocurable resin cured in situ via light, and an AI tool for patient-specific sizing and material tuning.
Services
Regulatory pathway definition and preclinical/clinical testing planning performed with a medical-device-focused CRO to support FDA submissions.
Regulatory pathway definition and preclinical/clinical testing planning performed with a medical-device-focused CRO to support FDA submissions.
Expertise Areas
- Intramedullary fixation and orthopedic implant development
- Photocurable biomaterials for bone repair
- Carbon-fiber-reinforced composite implants
- AI-driven patient-specific implant design
Key Technologies
- Carbon-fiber-reinforced composite sleeves
- Photocurable polymeric resins
- Light-mediated in-situ polymerization
- AI-based design optimization
News & Updates
Company attendance at the Orthopedic Research Society Annual Meeting, scheduled February 2-6, 2024, in Long Beach, CA.
NSF SBIR Phase I award details and abstract are available via the NSF seedfund entry.
Received NSF SBIR Phase I funding of $273,563 for design and development of the minimally-invasive intramedullary fixation technology.
Investment by UAVenture Capital Fund II LLC to support technology development.
Company attendance at the Orthopedic Research Society Annual Meeting, scheduled February 2-6, 2024, in Long Beach, CA.
NSF SBIR Phase I award details and abstract are available via the NSF seedfund entry.
Received NSF SBIR Phase I funding of $273,563 for design and development of the minimally-invasive intramedullary fixation technology.
Investment by UAVenture Capital Fund II LLC to support technology development.